COMPANY NAME	REVENUES 12 Months Ending Q1 2026	MARKET SHARE 12 Months Q1 2026	MARKET SHARE MRQ Q1 2026	MARKET SHARE A Quarter Before Q4 2025
Definium Therapeutics Inc	0.00	0.00%	0.00 %	0.00 %
Sage Therapeutics Inc	70.41	93.20%	93.66%	78.33%
Ataibeckley Inc	3.49	4.62%	2.82%	5.94%
Biocorrx Inc	1.16	1.54%	0.26%	1.19%
Pasithea Therapeutics Corp	0.49	0.64%	0.00%	8.59%
Nrx Pharmaceuticals Inc	0.00	0.00%	3.26%	5.95%

6 more competitors available

Note: Market share is calculated based on total revenue. To get a more accurate picture of Definium Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Definium Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.